Real-World Effectiveness of Nirmatrelvir-Ritonavir and Its Acceptability in High-Risk COVID-19 Patients.

Min-Kyoung Kim Kyung-Shin Lee Sin Young Ham Youn Young Choi Eunyoung Lee Seungjae Lee Bora Lee Jae-Hyun Jeon Bum Sik Chin Yeonjae Kim Gayeon Kim Hee-Chang Jang Jae Phil Choi Wan Beom Park

Published in: Journal of Korean medical science (2023)

Nirmatrelvir-ritonavir treatment significantly reduced oxygen therapy requirements in high-risk patients with COVID-19 during the omicron variant surge in South Korea. Physicians are encouraged to consider the active use of nirmatrelvir-ritonavir and to be watchful for gastrointestinal symptoms during medication.

Keyphrases

antiretroviral therapy
primary care
randomized controlled trial
sars cov
systematic review
healthcare
emergency department
depressive symptoms
replacement therapy
mesenchymal stem cells
physical activity
smoking cessation